Multivalent Presentation of Growth Factors Regulates Cellular Responses
Multivalent Presentation of Growth Factors Regulates Cellular Responses
批准号:
9468334
负责人:
Dominik R Haudenschild
金额:
$31.68万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-10 至 2022-01-31
关键词:
ActinsAdverse effectsAffectAmericanAnimal ModelAtomic Force MicroscopyBMP2 geneBindingBinding ProteinsBinding SitesBiochemistryBiologyBone DiseasesBone GrowthBone Morphogenetic Protein 10Bone Morphogenetic ProteinsBone RegenerationBuffersCartilageCartilage MatrixCell CommunicationCell TherapyCellsClinicClinicalCollaborationsCollagenDataDefectDoseEngineeringEnvironmentExtracellular MatrixFDA approvedFormulationFractureGene ExpressionGeneric DrugsGluesGoalsGrowth FactorHomeostasisHomoImaging DeviceIn VitroIndividualInjuryInvestigationKnowledgeMAPK14 geneMediatingMembraneModelingModern MedicineMolecularNanotechnologyNatural regenerationNatureOsteogenesisPatientsPeptide antibodiesPhysiologic OssificationPhysiologicalPre-Clinical ModelProcessProtein Binding DomainProteinsProteoglycanRattusResearchResearch PersonnelResolutionSignal TransductionSite-Directed MutagenesisSolidSpinalSpinal FusionStem cellsStructureSurgeonSwimmingTestingTimeTranslatingTransmission Electron MicroscopyValidationWorkbasebioimagingbonebone engineeringbone growth factorbone morphogenetic protein receptorsclinically relevantdesigndosageeffective therapyhigh resolution imagingimprovedin vivoin vivo Modelinsightinterdisciplinary approachmacromolecular assemblymammalian COMPmicroscopic imagingmolecular modelingmonomerneutralizing antibodynovel strategiesosteogenicosteogenic proteinpre-clinicalprotein complexprotein functionreceptorreconstitutionrecruitrepairedresponserhostem cell differentiation
中文摘要
数以百万计的美国人和全世界的人由于受伤、骨缺损、
和脊柱缺损,因此非常需要有效的治疗方法来再生骨骼。
促进骨骼生长在现代医学正在探索的治疗方法中,
给予生长因子,促使我们自己的身体再生骨骼,
有吸引力的方向,由于其非侵入性和利用我们自己的细胞,包括骨-
形成干细胞这种用骨生长因子治疗的方法已经被FDA批准
并成功地用于临床,然而,这种治疗的公认缺点是,
施用极高剂量的非常纯的生长因子不可避免地引起严重的副作用,
对一些患者的影响。我们的团队认为,目前的高剂量是没有必要的,
将生长因子呈递给细胞的策略,例如5种生长因子结合在一起作为一种明确的
相对于1000个单独的生长因子分子在细胞周围游动。与此
研究,我们希望开发出比目前更有效的方法来呈现生长因子
注射高剂量的方法。我们的方法受到自然本身的启发
“管理”这些生长因子,它总是与其他蛋白质结合,
提供必要的环境并帮助微调细胞反应。该提案基于
我们发现COMP是一种最初从软骨中分离出来的蛋白质,
所有的生长因子都在一次。我们计划研究COMP如何与生长因子结合,
每个COMP可以携带的生长因子(1到10),以及哪种情况最适合
骨再生我们相信我们的结果将证明这种多价结合
提供了一个新的平台,将生长因子呈递给干细胞,细胞对此做出反应,
显著增强的活动,包括强健的骨形成和生长。的结果
这项研究将大大提高我们目前对骨生长因子
在细胞水平上调节骨形成,使我们向非侵入性和
干细胞治疗骨再生
英文摘要
Millions of Americans and people worldwide suffer bone diseases due to injuries, bone defects,
and spinal defects, and therefore are in great need of effective treatments to regenerate bone
and promote bone growth. Among treatments being explored in modern medicine,
administration of growth factors that prompt our own body to regrow bone represents an
attractive direction due to its non-invasiveness and utilization of our own cells, including bone-
forming stem cells. Such treatment with bone growth factors has been approved by the FDA
and is successfully used in clinics, however a recognized drawback of this treatment is that the
administration of extremely high doses of very pure growth factor inevitably causes severe side
effects in some patients. Our team believes current high doses are not necessary, with better
tactics to present growth factors to cells, e.g. 5 growth factors bound together as a well-defined
cluster versus 1000 individual growth factor molecules swimming around the cells. With this
research, we hope to develop more effective ways to present growth factors than the current
approach of injecting high dosage. Our approach is inspired by the way nature itself
‘administers’ these growth factors, which is always in combination with other proteins that
provide the necessary context and help fine-tune cellular responses. This proposal builds on
our discovery that COMP, a protein originally isolated from cartilage, can bind to multiple bone
growth factors all at once. We plan to study how the COMP binds to growth factors, how many
growth factors each COMP can carry (1 to 10), and which of the situations work best towards
bone regeneration. We believe our results shall demonstrate that this multi-valent binding
provides a new platform to present the growth factors to stem cells, to which cells respond with
dramatically enhanced activities including robust bone formation and growth. The results from
this investigation shall greatly enhance our current understanding of how bone growth factors
regulate bone formation at the cellular level, and bring us a giant step closer to non-invasive and
stem cell based therapy for bone regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In situ and real-time readout of nuclear mechanotransduction via single cell mechanics and site-specific fluorescence reporting
-
批准号:10745440
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2023
-
负责人:Dominik R Haudenschild
-
依托单位:
Multivalent Presentation of Growth Factors Regulates Cellular Responses
-
批准号:9312194
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2017
-
负责人:Dominik R Haudenschild
-
依托单位:
Novel Early Intervention to Prevent Post-Traumatic Osteoarthritis
-
批准号:8360907
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2012
-
负责人:Dominik R Haudenschild
-
依托单位:
Novel Early Intervention to Prevent Post-Traumatic Osteoarthritis
-
批准号:8507602
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2012
-
负责人:Dominik R Haudenschild
-
依托单位:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
-
批准号:8099961
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2011
-
负责人:Dominik R Haudenschild
-
依托单位:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
-
批准号:8249814
-
项目类别:
-
资助金额:$7.69万
-
财政年份:2011
-
负责人:Dominik R Haudenschild
-
依托单位:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
-
批准号:8461068
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2011
-
负责人:Dominik R Haudenschild
-
依托单位:
海外基金